A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...

The ALPHA Project: What is it? ALPHA stands for Addressing Lupus Pillars for Health Advancement. The Project is a comprehensive, multi-phase, global consensus initiative aimed not only at identifying ...

Having lupus can make everyday life challenging. When your lupus is active, symptoms like joint stiffness, pain, fatigue, confusion, or depression can make simple tasks difficult — and sometimes ...

We are dedicated to providing support to individuals living with lupus wherever they live through our network of chapters across the country. Find local events, news and more.

IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including ...

The history of lupus can be divided into three periods: classical, neoclassical, and modern. This article concentrates on developments in the present century which have greatly expanded our knowledge ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of ...

Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...

Marlene Thames clearly remembers cleaning her Charlotte, NC, home and heading to the space under the stairs to retrieve her Christmas decorations. The next thing she remembers is waking on the floor ...

Stay up to date on the latest lupus information, research, and clinical guidelines and find resources for your patients. Thank you for all you do to care for people with lupus. Whether you are a ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.